Neurol. praxi. 2007;8(4):231-234

Diagnostika a terapie závrativých stavů

doc. MUDr. Jaroslav Jeřábek
Neurologická klinika 2. LF UK a FN Motol, Praha

Předkládaná práce sumarizuje základní diagnostiku u závrativých stavů a shrnuje terapeutické postupy u nejčastějších typů závrativých potíží.

Keywords: závrať, vertigo, nestabilita, nystagmus, vestibulární neuronitida, vestibulární migréna, Ménie` rova choroba, hypakuse, tinnitus, oscilopsie, benigní paroxysmální polohové vertigo, pulzní test

Published: November 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jeřábek J. Diagnostika a terapie závrativých stavů. Neurol. praxi. 2007;8(4):231-234.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ambler Z, Jeřábek J. Diferenciální diagnostika závratí. Praha; Triton, 2001.
    2. ArbusowV, Theil D, StruppM, et al. HSV-1 not only in human vestibular ganglia but also in the vestibular labyrinth. Audiol Neurootol 2001; 6: 259-262. Go to original source... Go to PubMed...
    3. Brandt T, Steddin S. Current view of the mechanisms of benign paroxysmal positioning vertigo: cupulolithiasis or canalolithiasis? J Vest Res 1993; 3: 373-382.
    4. Cohen HS, Jeřábek J. Efficacy of treatments for posterior canal benign paroxysmal positional vertigo. Laryngoscope 1999; 109: 584-590. Go to original source... Go to PubMed...
    5. Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Investig Drugs 2001; 10: 1831-1845. Go to original source... Go to PubMed...
    6. Furuta Y, Takasu T, Fukuda S, et al. Latent herpes simplex virus type 1 in human vestibular ganglia. Acta Otolaryngol Suppl 1993; 503: 85-89. Go to original source... Go to PubMed...
    7. Hashimoto M, Ohtsuka K, Suzuki Y, et al. Superior oblique myokymia caused by vascular compression. J Neuroophthalmol 2004; 24: 237-239. Go to original source... Go to PubMed...
    8. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004; 25: 544-552. Go to original source... Go to PubMed...
    9. Jen J, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004; 62: 17-22. Go to original source... Go to PubMed...
    10. Jeřábek J. Polohové vertigo. Čes Slov Neurol Neurochir 2001; 64/97: 333-337. Go to original source... Go to PubMed...
    11. Karlberg M, Annertz M, Magnusson M. Acute vestibular neuritis visualized by 3-T magnetic resonance imaging with high-dose gadolinium. Arch Otolaryngol Head Neck Surg 2004; 130: 229-232. Go to original source... Go to PubMed...
    12. Rosenberg MI, Glaser JS. Superior oblique myokymia. Ann Neurol 1983; 13: 667-669. Go to original source... Go to PubMed...
    13. Smith PF, Darlington CL. Pharmacology of the vestibular system. Baillieres Clin Neurol 1994; 3: 467-484. Go to PubMed...
    14. Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351: 354-361. Go to original source... Go to PubMed...
    15. Strupp M, Kalla R, Dichgans M, et al. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004; 62: 1623. Go to original source... Go to PubMed...
    16. Waterston J. Chronic migrainous vertigo. J Clin Neurosci 2004; 11: 384-388. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.